Narix Pharmaceuticals Private Limited

Seroflo 250 Inhaler contains a combination of Salmeterol Xinafoate and Fluticasone Propionate, used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting bronchodilator that relaxes airway muscles, while Fluticasone is a corticosteroid that reduces airway inflammation, helping prevent asthma attacks and improve breathing control.

International buyers frequently search for Seroflo 250 inhaler exporter, Salmeterol Fluticasone inhaler supplier, asthma inhaler wholesale, COPD inhaler exporter from India, respiratory inhaler manufacturer, and combination inhaler exporter.

Manufactured under GMP standards, Seroflo 250 Inhaler is supplied in sealed, export-grade inhaler devices with proper labeling and documentation suitable for global pharmaceutical distribution.

Applications
Used in pulmonology and respiratory care for asthma and COPD management. Supplied to hospitals, clinics, and pharmaceutical wholesalers worldwide.

Dosage & Storage
Dosage as prescribed by a healthcare professional. Store below 30°C, protected from direct sunlight and moisture.

Export & Supply
Narix Pharmaceuticals Pvt Ltd is a trusted exporter and supplier of Seroflo 250 Inhaler from India. We export respiratory medicines to USA, UK, Australia, Vietnam, Singapore, providing secure packaging, competitive pricing, and complete export documentation.

Why Choose Us
Buyers searching for asthma inhaler supplier India, Seroflo inhaler exporter, respiratory medicine wholesale, or COPD inhaler exporter trust Narix Pharmaceuticals Pvt Ltd for quality assurance, regulatory compliance, and dependable international supply.

Seroflo 125 Inhaler is a respiratory medication primarily used to treat and prevent asthma and chronic obstructive pulmonary diseases (COPD) like bronchitis (inflammation of the lining of your bronchial tubes) and emphysema (shortness of breath).